Harmony Biosciences Holdings, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Harmony Biosciences Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $61.7M, a 4.34% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $175M, a 12.1% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2023 was $192M, a 59.8% increase from 2022.
  • Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2022 was $120M, a 37.3% increase from 2021.
  • Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2021 was $87.5M, a 415% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $192M +$71.8M +59.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $120M +$32.7M +37.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $87.5M +$70.5M +415% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $17M +$163M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 -$146M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.